Cirtec Medical, Alajuela, Costa Rica announced that it is more than doubling its manufacturing footprint in the Coyol Free Zone to meet rising needs in neuromodulation, interventional, electrophysiology and structural heart markets. The 50,000-plus square foot expansion will add extrusion, braiding, coil winding, device assembly and packaging capabilities alongside the company’s existing facility.
The move is expected to accelerate customers’ time-to-market, optimize costs through greater vertical integration and broaden the company’s end-to-end product-lifecycle services, which span research and development in the U.S. through production in Costa Rica.
Cirtec’s chief executive explained that Costa Rica has evolved into a vital hub for high-quality medical device manufacturing, and the enlarged site will deliver faster turnaround and expanded offerings while preserving quality standards.
Costa Rica’s minister of foreign trade noted that the investment underscores the country’s appeal for foreign direct investment, reflecting confidence in its institutional framework, investment promotion policies and stability to host complex global operations. The foreign trade agency’s general manager added that the expansion demonstrates the maturity of Costa Rica’s industrial ecosystem, access to specialized talent and competitive conditions that attract medical-technology leaders.
Cirtec’s local general manager said the additional capacity will allow the team to leverage a highly educated workforce to shorten development timelines and enhance flexibility for customers worldwide.
